Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-21

Clinical Trial Update: An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023) [Phase 3]

View source ↗

Summary

Phase 3 trial update for an investigational drug in type 2 diabetes mellitus; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK0431-023 (null)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-07-21